Skip to Main Content

Paper Details

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma.
Neurooncol Adv
33
2020
Author NameAffiliation
Gavin P DunnWashington University School of Medicine
Albert H KimWashington University School of Medicine
  • 1 - 2

Datasets

Release 1.2